Otros idiomas Augmedix, Inc.

Acciones

AUGX

US05105P1075

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
2,85 ^USD	+2,15 %		-4,68 %	-51,28 %

24/04	Augmedix lanza el primer producto de documentación médica totalmente automatizado y potenciado por GenAI de la industria para los servicios de urgencias	CI
12/04	Insider de Augmedix vendió acciones por valor de 369.285 dólares, según un reciente registro de la SEC	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Augmedix Awarded on Newsweek’s World’s Best Digital Health Companies 2024 List	25/04
Augmedix Launches Industry’s First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments	24/04
Augmedix Launches Industry's First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments	24/04
Augmedix Insider Sold Shares Worth $369,285, According to a Recent SEC Filing	12/04
North American Morning Briefing : Traders Await -2-	10/04
Augmedix Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual Care	09/04
Augmedix, Inc. Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual Care	09/04
Augmedix Insider Sold Shares Worth $454,454, According to a Recent SEC Filing	05/04
Augmedix Insider Sold Shares Worth $380,108, According to a Recent SEC Filing	04/04
Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide	04/04
Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide	04/04
Top Midday Gainers	19/03
Augmedix Shares Surge 15% Premarket Tuesday as Revenue Growth Beats Expectations, Gross Margins Expand in Q4	19/03
Earnings Flash (AUGX) AUGMEDIX Reports Q4 Revenue $12.7M, vs. Street Est of $12.4M	18/03
Augmedix Delivers 45% Revenue Growth and Expanded Gross Margins for Fourth Quarter of 2023	18/03
Augmedix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	18/03
Augmedix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	18/03
Augmedix Provides Revenue Guidance for the Year 2024	18/03
Augmedix Announces New Positive Data and Enhancements to Its Ambient AI Product, Augmedix Go	12/03
Augmedix Announces New Positive Data and Enhancements to Its Ambient AI Product, Augmedix Go	12/03

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Augmedix, Inc.

Acciones

AUGX

US05105P1075

Otros idiomas

Filtros